Literature DB >> 17509389

Psychosocial and behavioral status of patients undergoing bariatric surgery: what to expect before and after surgery.

Thomas A Wadden1, David B Sarwer, Anthony N Fabricatore, LaShanda Jones, Rebecca Stack, Noel S Williams.   

Abstract

Extreme obesity, characterized by a body mass index (BMI) of 40 kg/m(2) or greater, is associated with significantly increased mortality, principally from cardiovascular disease, type 2 diabetes, and several cancers. It also is associated with an increased risk of psychosocial complications, including depression, eating disorders, and impaired quality of life. This article briefly examines the psychosocial status of extremely obese individuals who seek bariatric surgery and describes changes in functioning that can be expected with surgically induced weight loss. The article combines a review of the literature with clinical impressions gained from the more than 2500 candidates for bariatric surgery whom the authors have evaluated at the Hospital of the University of Pennsylvania.

Entities:  

Mesh:

Year:  2007        PMID: 17509389     DOI: 10.1016/j.mcna.2007.01.003

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  44 in total

Review 1.  Bariatric surgery: cost-effectiveness and budget impact.

Authors:  Lorenzo Terranova; Luca Busetto; Annarita Vestri; Marco Antonio Zappa
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

2.  Axis I psychopathology in bariatric surgery candidates with and without binge eating disorder: results of structured clinical interviews.

Authors:  LaShanda R Jones-Corneille; Thomas A Wadden; David B Sarwer; Lucy F Faulconbridge; Anthony N Fabricatore; Rebecca M Stack; Faith A Cottrell; Melissa E Pulcini; Victoria L Webb; Noel N Williams
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

Review 3.  Psychosocial evaluation for bariatric surgery: the Boston interview and opportunities for intervention.

Authors:  Stephanie Sogg; DeAnna L Mori
Journal:  Obes Surg       Date:  2008-09-16       Impact factor: 4.129

4.  Effect of mood and eating disorders on the short-term outcome of laparoscopic Roux-en-Y gastric bypass.

Authors:  Amy A Gorin; Ioannis Raftopoulos
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129

5.  Antidepressant drug therapy does not affect weight loss one year after gastric bypass surgery.

Authors:  Margaret Malone; Sharon A Alger-Mayer; John M Polimeni
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

6.  Mental Health Support Provided Throughout the Bariatric Surgery Clinical Pathway in French Specialized Care Centers for Obesity.

Authors:  Kristopher Lamore; Sandra S Kaci; Sébastien Czernichow; Marion Bretault; Jean-Luc Bouillot; Anne-Jeanne Naudé; Sandra Gribe-Ouaknine; Claire Carette; Cécile Flahault
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

7.  Sleeve Gastrectomy: Correlation of Long-Term Results with Remnant Morphology and Eating Disorders.

Authors:  Daniele Tassinari; Rossana D Berta; Monica Nannipieri; Patrizia Giusti; Luca Di Paolo; Daniela Guarino; Marco Anselmino
Journal:  Obes Surg       Date:  2017-11       Impact factor: 4.129

8.  Psychopathological similarities and differences between obese patients seeking surgical and non-surgical overweight treatments.

Authors:  Giovanni Castellini; Lucia Godini; Silvia Gorini Amedei; Valentina Galli; Giovanna Alpigiano; Elena Mugnaini; Marco Veltri; Alessandra H Rellini; Carlo Maria Rotella; Carlo Faravelli; Marcello Lucchese; Valdo Ricca
Journal:  Eat Weight Disord       Date:  2013-09-08       Impact factor: 4.652

Review 9.  Psychological Impact of Severe Obesity.

Authors:  Jennifer Collins; Chelsea Meng; Anna Eng
Journal:  Curr Obes Rep       Date:  2016-12

10.  Health and health-related quality of life: differences between men and women who seek gastric bypass surgery.

Authors:  Ronette L Kolotkin; Ross D Crosby; Richard E Gress; Steven C Hunt; Scott G Engel; Ted D Adams
Journal:  Surg Obes Relat Dis       Date:  2008-06-30       Impact factor: 4.734

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.